deluxepharmacy.net is explicitly listed in FDA’s September 19, 2017 warning letter to Bulk2USA. The agency said the websites identified in that letter offered unapproved and misbranded drugs to consumers in the United States. Anyone assessing an online medicine offer should examine that dated record alongside the seller’s licensing, prescription requirements, and pharmacist contact details.
FDA’s BeSafeRx guidance identifies several checks before ordering: the pharmacy should require a doctor’s prescription, provide a physical address and telephone number in the United States, have a licensed pharmacist available, and hold state pharmacy licensing. These are practical safeguards for evaluating the actual dispensing business before sharing health records or paying for a medicine.
deluxepharmacy.net and the FDA letter
The deluxepharmacy.net warning letter discusses prescription products sold without prescriptions and products lacking approved applications. It asks the recipient to stop marketing the identified violative products. The document’s table supplies the specific deluxepharmacy.net connection. Its findings should be attributed to FDA and tied to the date of the letter, rather than expanded into unsupported claims about every later seller.
The letter explains that medicines bypassing regulatory safeguards may be counterfeit, contaminated, or contain different ingredients or amounts than expected. That concern extends beyond whether a package arrives. A medicine purchase should be evaluated for its dispensing source and regulatory safeguards, because a delivered product can still pose a health risk despite resembling the advertised item.
deluxepharmacy.net prescription and licensing checks
Use FDA’s state board links to search the license of the pharmacy actually dispensing the order. FDA says an online pharmacy that is not listed should not be used. For an offer mentioning deluxepharmacy.net, compare the business identity and address with the official record, instead of relying on a badge or license claim displayed by the seller.
A license lookup is one part of the check. FDA also tells buyers to confirm that the pharmacy requires a prescription and makes a licensed pharmacist available for questions. The online pharmacy scam guidance explains related warning signs. Keep the focus on the actual seller handling the medication, prescription information, and payment for the proposed order.
| Check | FDA’s recommended safeguard |
|---|---|
| Prescription | A doctor’s prescription is required |
| License | The pharmacy appears in the state board database |
| Contact | A physical address and telephone number in the United States |
| Professional access | A licensed pharmacist answers questions |
Warning signs in medicine and packaging
FDA warns about online pharmacies offering unusually deep discounts, charging for unordered products, or failing to provide clear protections for personal and financial information. Those signs should prompt further checking before another order. A low price or convenient checkout should not replace confirmation of the prescription process and the pharmacy’s identity through the relevant official records.
FDA also lists medicine that differs from a local pharmacy’s supply, damaged packaging, and missing or expired dates as warning signs. Preserve the product information and ask a licensed pharmacist or clinician about the concern. The package’s appearance should not be used alone to decide whether an unfamiliar medicine can safely replace a prescribed product.
What to do about a suspected medicine problem
FDA’s BeSafeRx program separates reports of unlawful online medicine sales from reports of unexpected medication effects. Use the reporting links on its official page to choose the appropriate route. This distinction helps describe whether the concern is a seller’s conduct, the product itself, or an experience after using the medicine purchased through that seller.
MedWatch is FDA’s safety reporting program for patients, consumers, and health professionals. It receives reports involving medicines and other regulated products, and FDA may publish safety alerts when appropriate. Keep the product name, packaging, and purchase details available when describing a concern. A safety report serves a different purpose from contacting a bank about a charge.
Where to report and request a refund
FDA’s BeSafeRx page provides links for suspected unlawful sales and unexpected medicine effects. Financial deception can also be described to the FTC through its fraud reporting portal. Organize pharmacy receipts using the report preparation guide, including the advertised product, payment method, seller communications, and the specific reason the buyer is concerned about the transaction.
The FTC recommends contacting the company used to send money immediately if a payment was obtained through deception, then asking for a reversal or refund. Use the official bank or card issuer contact route. Describe the exact payment and order problem, and preserve the receipt, shipping information, and any correspondence supporting the request for review.
For credentials disclosed through a suspicious pharmacy checkout, the FTC recommends a new password, changes to other accounts sharing that password, and two-factor authentication. A later caller promising a refund in exchange for another payment requires separate scrutiny. The recovery scam guide explains how a new demand can compound the financial harm from an earlier transaction.
Questions and answers
Does an official record name deluxepharmacy.net?
Yes. FDA’s September 19, 2017 warning letter to Bulk2USA includes deluxepharmacy.net in its table of websites. The letter addresses unapproved and misbranded drug sales through the listed websites. That is a dated regulatory record, rather than a current inventory report.
Does a professional-looking pharmacy page establish safety?
FDA recommends checking the pharmacy’s license through the relevant state board. It also advises confirming a prescription requirement, a physical address and telephone number in the United States, and access to a licensed pharmacist. Appearance alone does not complete those checks.
What if the pharmacy is absent from the state database?
FDA’s license lookup guidance says not to use an online pharmacy that is not listed in the state board’s database. A buyer should search the official record before submitting a prescription, payment information, or an order for medication.
Which packaging problems deserve attention?
FDA lists damaged packaging, missing expiration dates, expired medicine, and medicine that looks different from a local pharmacy’s supply among warning signs. A patient should discuss a suspect product with a licensed pharmacist or clinician rather than assume it is interchangeable.
How can an unexpected medication reaction be reported?
FDA directs consumers experiencing an unexpected effect associated with a medicine to MedWatch. Its safety reporting program accepts reports from patients, consumers, and health professionals. A safety report should describe the product and experience, separately from any request for reimbursement.
How can a disputed deluxepharmacy.net payment be raised?
Contact the payment provider promptly with the medicine order, receipt, and pharmacy correspondence, following FTC recovery guidance. Describe the actual transaction problem instead of treating the FDA’s 2017 letter as proof about every later purchase. Product safety concerns also warrant a separate FDA report.
Sources
- Bulk2USA warning letter, September 19, 2017 · Food and Drug Administration
- Considering an Online Pharmacy? · Food and Drug Administration
- Locate a State-Licensed Online Pharmacy · Food and Drug Administration
- BeSafeRx online pharmacy information and reporting · Food and Drug Administration
- MedWatch safety reporting · Food and Drug Administration
- What To Do if You Were Scammed · Federal Trade Commission